Author Question: Increasing the field size results in: patient dose increasing radiographic density decreasing all ... (Read 32 times)

2125004343

  • Hero Member
  • *****
  • Posts: 566
Increasing the field size results in:
 
 patient dose increasing
  radiographic density decreasing
  all of these answers apply
  radiographic contrast increasing

Question 2

A timing device that automatically terminates exposure once density has reached the image receptor is:
 
 synchronous timer
  electronic timer
  automatic timer
  kilovolt peak meter



Bigfoot1984

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

patient dose increasing

Rationale: Increasing the field size results in increased patient dose as well as scatter radiation, this resulting in increased radiographic density and decreased radiographic contrast.

Answer to Question 2

automatic timer

Rationale: An automatic timer or photo timer is designed to terminate the exposure once sufficient density has reached the image receptor.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The tallest man ever known was Robert Wadlow, an American, who reached the height of 8 feet 11 inches. He died at age 26 years from an infection caused by the immense weight of his body (491 pounds) and the stress on his leg bones and muscles.

Did you know?

Alzheimer's disease affects only about 10% of people older than 65 years of age. Most forms of decreased mental function and dementia are caused by disuse (letting the mind get lazy).

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library